These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26719704)

  • 21. 7TM Domain Structure of Adhesion GPCRs.
    de Graaf C; Nijmeijer S; Wolf S; Ernst OP
    Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme.
    Dai S; Wang X; Li X; Cao Y
    Biochem Biophys Res Commun; 2015 Nov; 467(2):204-10. PubMed ID: 26449464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.
    Hamann J; Aust G; Araç D; Engel FB; Formstone C; Fredriksson R; Hall RA; Harty BL; Kirchhoff C; Knapp B; Krishnan A; Liebscher I; Lin HH; Martinelli DC; Monk KR; Peeters MC; Piao X; Prömel S; Schöneberg T; Schwartz TW; Singer K; Stacey M; Ushkaryov YA; Vallon M; Wolfrum U; Wright MW; Xu L; Langenhan T; Schiöth HB
    Pharmacol Rev; 2015; 67(2):338-67. PubMed ID: 25713288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
    Majumder M; Nandi P; Omar A; Ugwuagbo KC; Lala PK
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
    Harding J; Burtness B
    Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remarkable similarities between the hemichordate (Saccoglossus kowalevskii) and vertebrate GPCR repertoire.
    Krishnan A; Almén MS; Fredriksson R; Schiöth HB
    Gene; 2013 Sep; 526(2):122-33. PubMed ID: 23685280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Mechanism of Regulated Release of Lasso/Teneurin-2.
    Vysokov NV; Silva JP; Lelianova VG; Ho C; Djamgoz MB; Tonevitsky AG; Ushkaryov YA
    Front Mol Neurosci; 2016; 9():59. PubMed ID: 27499734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion.
    Shashidhar S; Lorente G; Nagavarapu U; Nelson A; Kuo J; Cummins J; Nikolich K; Urfer R; Foehr ED
    Oncogene; 2005 Mar; 24(10):1673-82. PubMed ID: 15674329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
    Plate KH; Breier G; Weich HA; Mennel HD; Risau W
    Int J Cancer; 1994 Nov; 59(4):520-9. PubMed ID: 7525492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
    Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
    Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orphan G-protein-coupled receptors and natural ligand discovery.
    Howard AD; McAllister G; Feighner SD; Liu Q; Nargund RP; Van der Ploeg LH; Patchett AA
    Trends Pharmacol Sci; 2001 Mar; 22(3):132-40. PubMed ID: 11239576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New life for an old therapy: ELTD1 as a downstream target of angiogenesis.
    Tiek DM; Cheng SY
    Neuro Oncol; 2022 Mar; 24(3):412-413. PubMed ID: 35015881
    [No Abstract]   [Full Text] [Related]  

  • 39. KDR activation in astrocytic neoplasms.
    Carroll RS; Zhang J; Bello L; Melnick MB; Maruyama T; McL Black P
    Cancer; 1999 Oct; 86(7):1335-41. PubMed ID: 10506722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells.
    Sumbayev VV; Gonçalves Silva I; Blackburn J; Gibbs BF; Yasinska IM; Garrett MD; Tonevitsky AG; Ushkaryov YA
    Oncotarget; 2016 Jul; 7(29):45575-45583. PubMed ID: 27322212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.